Top Markets
#1 Status Status +19.17%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#3 GoPlus Security GoPlus Security +16.92%
#4 Wrapped NXM Wrapped NXM +15.51%
#5 Ontology Gas Ontology Gas +11.14%
#6 DMT-NAT DMT-NAT +8.98%
#7 Pons Pons +7.43%
#8 Nesa Nesa +7.39%
#9 Nillion Nillion +6.74%
#10 Provenance Blockchain Provenance Blockchain +6.49%
Coin of the day
Status Status
設定
言語
日本
通貨
USD
テーマ
TruScreen Group Limited TruScreen Group Limited

TruScreen Group Limited

TRU
株式のランク #34030
TruScreen Group Limited, alongside its subsidiaries, focuses on the... TruScreen Group Limited, alongside its subsidiaries, focuses on the development, manufacturing, and global distribution of advanced systems for cancer detection. Their commercial reach extends across various international territories, including Mexico, China, Russia, Vietnam, Zimbabwe, countries within Eastern Europe, the Middle East/North Africa region, and beyond. A flagship product is the TruScreen cervical cancer screening system, a specialized medical device engineered to provide real-time identification of precancerous and cancerous tissue present on the cervix. Established in 2013, the company, with its primary base of operations in Auckland, New Zealand, officially changed its name from TruScreen Limited to Truscreen Group Limited in August 2020.
株価
$0.00903546
時価総額
$6.38M
変化（1日）
0.00%
変化（1年）
-15.28%
国
NZ
取引 TruScreen Group Limited (TRU)

カテゴリー

Healthcare
TruScreen Group Limited（TRU）の利益
2026 時点の利益 TTM: 0
TruScreen Group Limited の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
TruScreen Group Limited の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US